Penpulimab and Anlotinib in PDL1 high-expression pulmonary giant cell carcinoma with cerebral metastases: case report and review
Pulmonary giant cell carcinoma (PGCC) is a rare subtype of non-small cell lung cancer (NSCLC) characterized by complex pathology, high rates of misdiagnosis or missed diagnosis, an aggressive clinical course, rapid progression, and poor prognosis. This case report describes a 67-year-old Chinese mal...
Saved in:
| Main Authors: | Minghong Xie, Yunlong Zhao, Xiaohua Hou, Ning Li, Sha Niu, Xinju Xu |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Frontiers Media S.A.
2024-12-01
|
| Series: | Frontiers in Oncology |
| Subjects: | |
| Online Access: | https://www.frontiersin.org/articles/10.3389/fonc.2024.1476205/full |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Anlotinib combined with penpulimab in the treatment of advanced adult thoracic spinal osteosarcoma: a case report
by: Xiaochun Chen, et al.
Published: (2025-07-01) -
Efficacy and safety of Cadonilimab plus anlotinib in small cell lung cancer with brain metastases
by: Hai-Zhen Yi, et al.
Published: (2025-07-01) -
The Efficacy of Anlotinib Plus Whole Brain Radiotherapy in Advanced Non‐Small Cell Lung Cancer With Multiple Brain Metastases: A Retrospective Study
by: Lipin Liu, et al.
Published: (2025-01-01) -
Stereotactic radiosurgery combined with anlotinib for limited brain metastases with perilesional edema in non‐small cell lung cancer: Rvision‐001 study protocol
by: Yuxia Wang, et al.
Published: (2020-05-01) -
The cost effectiveness of penpulimab with paclitaxel and carboplatin in first-line treatment of metastatic squamous non-small cell lung cancer
by: Kaiqi Zhu, et al.
Published: (2025-04-01)